The Cosmetic Ingredient Review (CIR) Expert Panel assessed the safety of cross-linked alkyl acrylates as used in cosmetics. The 23 cross-linked alkyl acrylates included in this safety assessment are reported to function as absorbents, film formers, emulsion stabilizers, viscosity increasing agents, suspending agents, binders, and/or skin-conditioning agents. The Panel reviewed available animal and clinical data, as well as information from previous CIR reports on monomer components. Because data were not available for the individual ingredients, and because residual monomer may be present, the Panel extrapolated from previous reports to support safety. The Panel concluded that cross-linked alkyl acrylates are safe in the present practices of use and concentration, provided that they are not polymerized in benzene. For those ingredients polymerized in benzene, the data available were insufficient to make a determination of safety. A risk assessment for the amount of benzene present would be needed.
In 2002, the Cosmetic Ingredient Review (CIR) published the Final Report on the Safety Assessment of Acrylates Copolymer and 33 Related Cosmetic Ingredients. 1 The Panel concluded that those ingredients were safe for use in cosmetics when formulated to avoid skin irritation. While copolymers are polymers synthesized from 2 or more different monomers, cross polymers are polymers that are cross-linked (ie, individual polymer chains are connected by bridging molecules [cross-linking agents]). Cross-linked polymers are generally less chemically reactive and less soluble (if not totally insoluble) than their respective non-cross-linked counterparts.
A CIR report on another family of polymers is also available. In 1982, the CIR published the Final Report on the Safety Assessment of Carbomers-934, -910, -934P, 940, -941, and -962, in which it was concluded that carbomers are safe as used. 2 That conclusion was reaffirmed in 2003. 3 A carbomer is a homopolymer of acrylic acid cross-linked with an allyl ether of pentaerythritol, an allyl ether of sucrose, or an allyl ether of propylene. 4 Due to the paucity of published safety and toxicity data on these ingredients, this report includes summary information included in technical data sheets, ingredient specification sheets, and material safety data sheets (MSDSs); this information is identified as such.
Chemistry

Definition and Structure
Cross-linked alkyl acrylates are cross-linked polymers in which the comonomers consist of at least 1 of the following: acrylic acid, sodium acrylate, methacrylic acid, or alkyl acrylate. Whereas polymers consisting purely of acrylic acid are often referred to as "carbomers," copolymers comprised of mixtures of acrylic acid and alkyl acrylate monomers may sometimes be referred to as "alkyl carbomers." In that vein, most of the ingredients in this report could be classified as cross-linked alkyl carbomers. For example, dodecyl (C12 alkyl) acrylate, acrylic acid, and methacrylic acid could be copolymerized and cross-linked with diallyl sucrose to form an acrylates/C10-30 alkyl acrylate cross polymer with the internal structure.
Accordingly, although all of the monomers and crosslinking agents may be the same, 2 polymers with very different physical properties may share the same name under INCI conventions. The definitions and structures of the ingredients included in this review are provided in Table 1 .
Physical and Chemical Properties
The available physical and chemical property information is provided in Table 2 . The properties of a single ingredient, such as the above cross polymer, can vary from a highly swellable, soft material to an unswellable, very hard material because of the multitude of possible reaction conditions and the methods involved in the manufacture of these polymers. The nature of these ingredients is highly dependent on the identity of the alcohol radicals of these acrylate esters (eg, the stearyl and lauryl groups of stearyl/lauryl methacrylate cross polymer). 5 Acrylate cross polymers that correspond to 1 INCI name often have many trade names, and production processes may vary for different trade name products bearing the same INCI name. Since the products may have different properties, the trade name is included in parenthesis when available.
The polymers in this group share a general lack of chemical reactivity that renders them nearly impervious to degradation. These ingredients are essentially insensitive to solar ultraviolet light (UV) degradation, as the primary UV absorption of acrylics is at a lower wavelength.
Method of Manufacture
Cross-linked alkyl acrylates are typically produced via free radical, head-to-tail chain-propagation polymerization. 5 The most common method is the emulsion method, but bulk and solution methods are also used. The marked variability in the identity of monomers and cross-linking agents, the ratio of comonomers, the order of addition of comonomers, the level of cross-linking, and other reaction conditions in the polymerization process can significantly alter the polymeric structure and properties of the product. 6 Additionally, postsynthesis, mechanical processing of these products can also significantly affect the consistency of these ingredients. These variables will likely differ from vendor to vendor, and possibly even from batch to batch. Table 3a lists the monomers used to create these cross polymers (based on INCI definition), and Table 3b names the crosslinking compounds and initiators used. 4 Acrylates/C10-30 alkyl acrylate cross polymer. According to a trade product technical data sheet, acrylates/C10-30 alkyl acrylate cross polymer (as Pemulen) is polymerized in an ethyl acetate-cyclohexane mixture. 7 Another source reports that acrylates/C10-30 alkyl acrylate cross polymer may be polymerized in benzene. 8 A third supplier reports that acrylates/C10-30 alkyl acrylate cross polymer is polymerized in n-hexane. 9 Acrylates/C10-30 alkyl acrylate cross polymer A copolymer of C10-30 alkyl acrylate and 1 or more monomers of acrylic acid, methacrylic acid or 1 of their simple b esters cross-linked with an allyl (2-propenyl) ether of sucrose or an allyl ether of pentaerythritol Emulsion stabilizer; viscosity increasing agent-aq; viscosity increasing agent-nonaq Acrylates/C12-13 alkyl methacrylates/ methoxyethyl acrylate cross polymer A copolymer of C12-13 alkyl methacrylates, methoxyethyl acrylate, and 1 or more monomers of acrylic acid, methacrylic acid, or 1 of their simple esters, cross-linked with vinyloxazoline
Hair fixative
Acrylates cross polymer 26794-61-6 (when R is butyl) 74464-10-1 (when R is isobutyl)
A copolymer of acrylic acid, methacrylic acid, or 1 of its simple esters, cross-linked with glycol dimethacrylate Absorbent (continued) The sodium salt of a copolymer of acrylic acid, methacrylic acid, or 1 or more of its simple esters, cross-linked with ethylene diglycidyl ether Absorbent (continued) Acrylates/vinyl neodecanoate cross polymer. Acrylates/vinyl neodecanoate cross polymer (as Aculyn 38 polymer) is manufactured by an emulsion polymerization process. 12 
Impurities and Residual Monomer or Solvent
Acrylates/C10-30 alkyl acrylate cross polymer. According to product specification sheets from 1 company, acrylates/C10-30 alkyl acrylate cross polymer can contain (total) residual solvent (ethyl acetate þ cyclohexane) at a maximum of 0.45% (Carbopol 1382; Carbopol Ultrez 20; Carbopol Ultrez 21) [13] [14] [15] or 0.5% (Pemulen TR1; Pemulen TR2; Carbopol ETD 2020). [16] [17] [18] Another supplier, who uses n-hexane as a solvent, reported that the maximum residual solvent in the polymer is 0.2% n-hexane. 9 As Carbopol 1342, the product specifications state that acrylates/C10-30 alkyl acrylate cross polymer can contain 0.5% Table 2 . Chemical and Physical Properties.
Property Description Reference
Acrylates/C10-30 alkyl acrylate cross polymer Appearance White powder; [13] [14] [15] [16] [17] [18] [19] Odor Slightly acetic [13] [14] [15] [16] [17] [18] [19] Activity, as supplied Approximately 100% active 8 Molecular weight >500 000 Da 8 Solubility swells in water 39 pH *2.5-3 at 1% in water 39 Heavy metals content 10 ppm (max), under all trade names [13] [14] [15] [16] [17] [18] [19] Specific gravity 1.4 (at 20 C) 39 Particle size (as tested by 1 source (max) residual benzene. 19 A supplier reported that analysis of 40 lots of Carbopol 1342 indicated that the average level of benzene was 0.25%, and the level ranged from 0.04% to 0.41% benzene. 20 (According to the European Commission Cosmetics Directive, benzene cannot be present as a constituent of other substances, or in mixtures, in concentrations equal to, or greater than 0.1% by weight. 21 As another point of reference, US Pharmacopeia limits for benzene for several carbomers manufactured with benzene range from 0.01% to 0.5%. 22 ) One source stated that residual monomer content of acrylates/C10-30 alkyl acrylate cross polymer (trade name not provided) is typically less than 0.25% acrylic acid and less than 0.5% residual ester (C10-30 alkyl acrylate), 8 while another stated that acrylic acid monomer content is <0.1%. 23 Acrylates cross polymer. One source reported that acrylates cross polymer contained <0.005% methyl methacrylate and <0.005% butyl acrylate, 24 and another reported 0.005% (max) of methyl methacrylate, ethylene methacrylate, and isobutyl methacrylate, and that acrylates cross polymer did not contain residual solvents or preservatives. 25 Acrylates/steareth-20 methacrylate cross polymer. The composition of acrylates/steareth-20 methacrylate cross polymer (as Aculyn 88 polymer) is stated as 28.0% to 30.0% acrylates/ steareth-20 methacrylate cross polymer, <0.01% residual monomer, 70.0% to 72.0% solvent (water), and 0.195% (max) sodium benzoate. 10 According to actual analytical specifications, the amount of residual ethyl acrylate present is 0.0001%.
Acrylates/vinyl isodecanoate cross polymer. The residual acrylic acid monomer content of acrylates/vinyl isodecanoate cross polymer (Stabylen 30) is reported to be <0.05% by weight. 11 Acrylates/vinyl neodecanoate cross polymer. The composition of acrylates/vinyl neodecanoate cross polymer (as Aculyn 38 polymer) is stated as 28.0% to 30.0% acrylates/vinyl neodecanoate cross polymer, <0.1% residual monomer, and 70.0% to 72.0% solvent (water). 12 According to actual analytical specifications, the amount of residual ethyl acrylate present was 0.0001%. Another source reported the residual monomer level of acrylates/vinyl neodecanoate cross polymer is <0.01%. 26 Lauryl methacrylate/glycol dimethacrylate cross polymer. The residual monomer levels of lauryl methacrylate/glycol dimethacrylate cross polymer are <0.01% lauryl methacrylate and <0.01 ppm ethylene glycol dimethacrylate. 27 Lauryl methacrylate/glycol dimethacrylate cross polymer has a residual solvent level of 0.1% isopropanol. The ingredient can contain up to 2% adsorbed water.
Sodium acrylates cross polymer 2. The maximum amount of residual monomer content in sodium acrylates cross polymer 2 (Aqua Keep 10SH-NFC) is 0.02%. 28 
Use
Cosmetic
Cross-linked alkyl acrylates are reported to function as absorbents, film formers, emulsion stabilizers, viscosity increasing agents, suspending agents, binders, and/or skin-conditioning agents in cosmetic formulations. 4 Acrylates/C10-30 alkyl acrylate cross polymer functions as a primary emulsifier in oil-inwater emulsions. 7 Voluntary Cosmetic Registration Program data obtained in 2011, 29 and the concentration of use information received in response to a survey conducted by the Personal Care Products Council, 30 indicates that 11 of the 23 crosslinked alkyl acrylates named in this report currently are used in cosmetic formulations. Acrylates/C10-30 alkyl acrylate cross polymer has the greatest number of uses, with 1,696 reported; 1,365 of those uses are in leave-on products. Acrylates cross polymer, acrylates/vinyl isodecanoate cross polymer, acrylates/vinyl neodecanoate cross polymer, allyl methacrylates cross polymer, lauryl methacrylate/glycol dimethacrylate cross polymer, lauryl methacrylate/sodium methacrylate cross polymer, and sodium acrylates/C10-30 alkyl acrylate cross polymer are all used in less than 75 formulations.
Some acrylates/C10-30 alkyl acrylate cross polymers are polymerized in benzene; the highest reported concentrations of use of this ingredient when polymerized in benzene are 0.4% and 1.1% for leave-on and rinse-off products, respectively. 31 The use concentrations for acrylates/C10-30 alkyl acrylate cross polymer not polymerized in benzene are up to 5% in leave-on and rinseoff products; 5% is the highest rinse-off concentration of use of the cross-linked alkyl acrylates. The highest concentration of use reported in leave-on cross-linked alkyl acrylates is 6% acrylates/ ethylhexyl acrylate cross polymer. 30 Frequency and concentration of use data are provided in Table 4a . The ingredients not reported to be used are listed in Table 4b .
Products containing some cross-linked alkyl acrylates may be applied to baby skin, used near the eye area or mucous membranes, or could possibly be ingested or inhaled. In practice, 95% to 99% of the particles released from cosmetic sprays have aerodynamic equivalent diameters in the 10 to 110 mm range. 32, 33 Therefore, most particles incidentally inhaled from cosmetic sprays would be deposited in the nasopharyngeal region and would not be respirable to any appreciable level. 34, 35 There is some evidence indicating that deodorant spray products can release substantially larger fractions of particulates having aerodynamic diameters in the range considered to be respirable. 35 However, the information is not sufficient to determine whether significantly greater lung exposures result from the use of deodorant sprays, compared to other cosmetic sprays.
All of the ingredients included in this review, with the exception of acrylates/C12-13 alkyl methacrylates methoxyethyl acrylate cross polymer and methacrylic acid/PEG-6 methacrylate/PEG-6 dimethacrylate cross polymer, are listed in the European Union inventory of cosmetic ingredients. 36 The 2 ingredients that are not included in the European Union inventory are in the process of being named and will be added once that process is complete. 37 Noncosmetic Acrylic ester polymers are used in coatings, textiles, adhesives, and paper manufacture. 5
Toxicokinetics
Published toxicokinetics, absorption, distribution, metabolism, and excretion data were not found for the cross polymers. Large polymeric structures, however, such as cross-linked alkyl acrylates, generally are not absorbed through the skin. Toxicokinetics data on some of the monomers are provided in Table 5 .
Effect on Skin Permeation
Acrylates/C10-30 alkyl acrylate cross polymer. A topical formulation vehicle that included acrylates/C10-30 alkyl acrylate cross polymer (Pemulen TR-2), in combination with PEG 400 and carbomer, reduced the permeation of N,N-diethyl-m-toluamide through skin. 38 Evaluations were made in vitro using excised rat skin and in vivo using Beagle dogs.
Toxicological Studies
To aid in the evaluation of the safety of these cross polymers, Table 5 provides a brief summary of relevant data on a number of monomer components. (This summary is not intended to be an all-encompassing review of these monomers.) inflammation, hyperplasia, and tumors were observed. 39 There were no observed adverse effects at exposures of 0.05 mg/m 3 .
Reproductive and Developmental Toxicity
Published reproductive and developmental toxicity data were not found. Reproductive and developmental toxicity data on some of the monomers are provided in Table 5 .
Genotoxicity
Genotoxicity data on some of the monomers are provided in Table 5 .
Acrylates/C10-30 alkyl acrylate cross polymer. Acrylates/C10-30 alkyl acrylate cross polymer, tested at 156 to 500 mg/plate in dimethyl sulfoxide, was not mutagenic in an Ames assay with Salmonella typhimurium TA98 and TA100. 23 It is not stated directly, but it appears that the studies were performed with and without metabolic activation.
Acrylates/Steareth-20 methacrylate cross polymer. The acrylic copolymer of acrylates/steareth-20 methacrylate cross polymer (as Aculyn 88 polymer) was not mutagenic in an Ames test, with or without metabolic activation. 10 (Study performed using good laboratory practices [GLP]; details not provided.)
Acrylates/vinyl neodecanoate cross polymer. The acrylic copolymer of acrylates/vinyl neodecanoate cross polymer (as Aculyn 38 polymer) was not mutagenic in an Ames test, with or without metabolic activation. 12 (GLP study; details not provided).
Sodium acrylates cross polymer 2. According to an industry MSDS, sodium acrylates cross polymer 2 (as Aqua Keep 10SH-NFC) was negative in an Ames test using S typhimurium TA98, TA100, TA1535, and TA1537 and Escherichia coli WP2uvrA. 41 
Carcinogenicity
Published carcinogenicity studies were not found. Carcinogenicity data on some of the monomers are provided in Table 5 .
Irritation and Sensitization
Irritation and sensitization data on some of the monomers are provided in Table 5 .
Skin Irritation and Sensitization
Dermal irritation and sensitization studies, using alternative methods and nonhuman and human test populations, are presented in Table 6 .
In an alternative method study, acrylates/vinyl neodecanoate cross polymer was predicted to be a nonirritant. The nonhuman studies reported no to slight irritation with undiluted and weak sensitization with 2% aq, acrylates/ C10-30 alkyl acrylate cross polymer, no irritation with acrylates cross polymer at 30% in olive oil, and no irritation or sensitization with sodium acrylates cross polymer 2 (concentration not specified). Mostly, human testing with undiluted acrylates/C10-30 alkyl acrylate cross polymer, acrylates cross polymer, and acrylates/ethylhexyl acrylate cross polymer, up to 2.5% aq acrylates/vinyl isodecanoate cross polymer, 1% aq dilutions of formulations containing 2% acrylates/vinyl neodecanoate cross polymer, and formulations containing up to 2.6% lauryl methacrylate/glycol dimethacrylate cross polymers do not indicate any dermal irritation or sensitization. The only exception was a weak irritant response noted during an intensified Shelanski human repeated insult patch test (HRIPT) with undiluted acrylates/C10-30 alkyl acrylate cross polymer.
Ocular Irritation
Alternative studies
Acrylates/vinyl isodecanoate cross polymer. The EYE-TEX alternative method was used to predict the in vivo ocular irritation classification of acrylates/vinyl isodecanoate cross polymer (as Stabylen 30) . 40 The results obtained in a standard volume-response study using samples of 100 ml test material corresponded to a Draize ocular irritation classification of nonirritant.
Lauryl methacrylate/glycol dimethacrylate cross polymer. The EpiOcular Human Cell Construct (3-(4,5-Dimethylthiazol-2yl)-2,5-Diphenyltetrazolium Bromide [MTT] assay), was used to assess the potential ocular irritation of a face powder containing 1% lauryl methacrylate/glycol dimethacrylate cross polymer. 42 The ET 50 (duration of exposure resulting in a 50% decrease in MTT conversion) of the test material was >1,440 minutes, which was the maximum exposure time. (As a reference point, the ET 50 of the positive control, 0.3% Triton X-100, was 16.3 minutes.)
Nonhuman
Acrylates/C10-30 alkyl acrylate cross polymer. The ocular irritation potential of acrylates/C10-30 alkyl acrylate cross polymer (as Carbopol ETD) was evaluated using groups of 3 albino rabbits. 43 The test material, undiluted and as a 1% neutralized solution (pH 6.9-7.0), was instilled into the conjunctival sac of 1 eye of each rabbit per group; the contralateral eyes served as a control. The eyes were not rinsed. The undiluted test material produced slight to moderate corneal and conjunctival irritation which cleared by day 7. Slight iridal and conjunctival irritation was observed with the 1% solution. All signs of irritation cleared within 72 hours.
In other studies using the same procedure, the ocular irritation potential of acrylates/C10-30 alkyl acrylate cross polymer (as Carbopol Ultrez 20 and Carbopol Ultrez 21) was evaluated using groups of 3 rabbits. 44, 45 The test material was evaluated undiluted and as a 5% dilution in distilled water. The undiluted test material produced moderate corneal irritation and conjunctival irritation which cleared by day 21. (The maximum mean score [MMS] was 37.7/110.) Moderate conjunctival irritation (MMS 9.3/110) was observed with the 5% solution, which was classified as a minimal irritant.
The ocular irritation potential of acrylates/C10-30 alkyl acrylate cross polymer (as Pemulen) was evaluated by instilling 0.021 g of the test article into the conjunctival sac of 1 eye of 9 New Zealand White rabbits. 46 The contralateral eyes were untreated and served as the control. At 30 seconds postinstillation, both eyes of 3 rabbits were rinsed; the eyes of the other 6 rabbits were not rinsed. The eyes were examined for irritation for up to 72 hours following dosing. "Significant" ocular irritation was observed in 3 of the 6 unrinsed eyes. At 24 hours after instillation, corneal opacity was observed in 3 and iritis in 1 unrinsed eye; minimal conjunctivitis was seen in all 6 unrinsed eyes. These observations were resolved by 72 hours. "Less severe responses" were observed in the rinsed eyes. Iritis was observed in 1 and conjunctivitis in 3 of the rinsed eyes at 24 hours after dosing. At 48 hours after dosing, conjunctivitis was observed in 1 rinsed eye. Based on the observations made for 
Monomer Component Parameter Evaluated
Outcome Reference Acrylic acid Toxicokinetics Dermal: radioactivity was recovered mostly in the skin trap, and then in expired CO 2 Oral: in numerous studies using rats, the dose was primarily excreted in expired air in most cases; elimination was generally rapid; uptake and elimination appeared to be biphasic; absorption and excretion were also rapid in mice Inhalation: rats were exposed to acrylic acid via inhalation; most of the radioactivity was found in the head and snout, with relatively large amounts also recovered in the upper respiratory tract 1 Toxicological studies Single dose-dermal: LD 50 -295-950 mg/kg in rabbits Oral: LD 50 -2,100-3,200 mg/kg in rabbits and rats; produced gastric lesions Inhalation: LC 50 -3,600 mg/m 3 in rats 1 Repeated dose-dermal: 4% produced toxic effects in mice in a 13-week study Oral: toxic effects were observed in rats in a 90-day drinking water study with doses of 750 mg/kg and in a 90-day gavage study in rats doses with 150 or 375 mg/kg; stomach lesions were not observed with up to 500 ppm in a 12-month drinking study with rats Inhalation: nasal irritation and/or lesions were observed in rats and/or mice exposed to 1500 ppm for 4-day up to 225 ppm for 2-week, 300 ppm for 20-day, and 75 ppm for 13-week 1 
Reproductive and developmental toxicity
Oral: did not produce teratogenic effects in rats, NOAEL of 250 mg/kg; did affect body weights and some organ weights in the parental animals Inhalation: not teratogenic or embryotoxic in rats at concentrations up to 120 ppm; did produce maternal toxicity at concentrations of 120 ppm and greater 1 Genotoxicity Genotoxic in mouse lymphoma assays, and in an in vitro cytogenetic assay; not genotoxic or mutagenic in Ames tests, unscheduled DNA synthesis (UDS) assay, micronucleus assay, in vivo transformation assay, Chinese hamster ovary (CHO)/HGPRT, in vivo cytogenetic assay, Drosophila test, or mouse dominant lethal assay 1 Carcinogenicity Dermal: in 1 study, 4% in acetone was a complete but weak carcinogen in mice; in another, 1% was not carcinogenic in mice Oral: not carcinogenic in rats when given in drinking water at up to 1200 ppm Parenteral: not carcinogenic when 1.4 mg was injected subcutaneously (sc) to mice IARC evaluation: no epidemiological data relevant to carcinogenicity were available; no experimental data relevant to carcinogenicity were available; not classifiable as to its carcinogenicity to humans (group 3)
Irritation and sensitization
Skin: 4% was irritating to the skin of mice Mucosal: a 1% solution caused significant injury to the rabbit eye 1 Methyl acrylate Toxicokinetics Dermal: in guinea pigs exposed dermally to methyl [2,3-14 C]acrylate, radioactivity was seen in the sc tissues and throughout the body Oral: the dose was primarily excreted in expired air; elimination was rapid (rats) 69 Toxicological studies
Single dose-oral: produced gastric lesions when given inhibited with 200 ppm hydroquinone monomethyl ether (HQMME) 1 Repeated dose-oral: not toxic when given orally to rats (details not provided) 1 
Reproductive and developmental toxicity
Inhalation: up to 200 ppm did not produce teratogenic or reproductive effects in rats 
74S
International Journal of Toxicology 36(Supplement 2) Repeated dose-oral: a 2-week study in rats with dosing via gavage or drinking water-gastric lesions were observed, primarily in the forestomach., at doses of 20 to 100 mg/kg given buy gavage and at concentrations1000 to 4000 ppm in drinking water; in a 13-week gavage study, doses of 200 mg/kg produced lesions in the forestomach of rats; stomach lesions were not observed at concentrations up to 2000 ppm in a 2-year drinking study with rats or up to 1000 ppm in a 2-year capsule study with dogs Inhalation: no nasal lesions were observed with up to 300 ppm in a 1-month study using rats and mice; nasal lesions were observed at concentrations of !242 ppm in rats in a 12-week study Butyl acrylate Toxicokinetics Oral: the dose was primarily excreted in expired air (rats) 1 Toxicological studies Single dose-oral: produced gastric lesions when given inhibited with 10 to 55 HQMME 1 Repeated dose-oral: not toxic when given orally to rats (details not provided) Inhalation: toxicity was observed in rats and hamsters upon three 6-hour exposures to 820 and 817 ppm, respectively; nasal lesions were observed in rats exposed to concentrations !108 ppm in a 13-week study 1 
Reproductive and developmental toxicity
Inhalation: no toxic effects were seen with 25 ppm; high concentrations had toxic effects on the fetuses and dams 
Irritation and sensitization
Dermal-nonhuman: not an irritant to rabbit skin when applied undiluted Human: not an irritant or sensitizer (concentration not given) Ocular: the greatest tolerated concentrations were 13% to 20% for unrinsed and 20% to 30% for rinsed rabbit eyes; in an irritant-threshold test, 2% was the greatest concentration that did not produce irritation in rabbit eyes 1 CIR conclusion (2002) Safe as used when formulated to avoid skin irritation 1 Methacrylic acid Toxicokinetics Readily absorbed through the mucous membranes of the lungs and gastrointestinal tract of and the skin, and is readily distributed to all major tissues 73 Animal toxicology Single dose-dermal: reported LD 50 values ranged from 500 to 1243 mg/kg for rabbits Oral: reported LD 50 values ranged from 827 to 1600 mg/kg for mice, 277 to 2260 mg/kg for rats, and 280 to 1200 mg/kg for rabbits Inhalation: reported LC 50 values were 3657 ppm in mice, 1350 ppm/4 h in rats, and 2522 ppm/1 h in rabbits 73 Repeated dose-oral: no signs of toxicity in a short-term study Inhalation: nose and eye irritation and weight loss in rats with 5 exposures to 1300 ppm; only renal congestion in rats with 20 exposures to 300 ppm; in a 2week study, repeated doses of !100 ppm caused reactions in rats, !500 ppm caused reactions in mice, and 1000 ppm killed all rats and mice; in a 90-day study, respiratory effects were seen in rats and mice exposed to 300 ppmcytomegaly of renal tubular epithelium was observed in >50% of test male mice 73 Reproductive and developmental toxicity Inhalation: no reproductive or developmental effects at concentrations up to 300 ppm In vitro: adverse effects were seen with exposure of rat embryos to !129 mg/ml 73 
Genotoxicity
Positive in a DNA cell-binding assay; negative in an Ames test 73 Carcinogenicity It was reported that IARC reviewed methacrylic acid, but did not prepare a monograph because inadequate data were available 73 
Irritation and sensitization
Dermal-nonhuman: corrosive to rabbit and guinea pig skin; in a guinea pig maximization study, it was difficult to determine if observed reactions were hypersensitivity or irritation; guinea pigs were not sensitized in 3 other studies Mucosal: caused severe corneal, iridal, and conjunctival effects in rabbits in 1 study; in an inhalation study, 56 916 ppm was corrosive to rabbit eyes 73 Clinical use Negative results were reported in a number of patch tests of patients allergic to methyl methacrylate and to workers exposed to acrylates 73 (continued)
76S
International Journal of Toxicology 36(Supplement 2) 
Discussion items
The Panel was concerned with the extreme corrosivity; a presentation demonstrated that a trained professional could apply the acid to the nail without exposure to the skin, but this could not be demonstrated for retail consumers; due to concerns that inhalation could affect the respiratory tract, and the nail technician could be subjected to increased exposure in a commercial setting, the NIOSH-recommended exposure limit of 20 ppm as a time-weighted average concentration should not be exceeded; the Consumer Product Safety Commission rule requires child-resistant packaging for liquid household products containing >5% methacrylic acid (wt to vol) 73 CIR conclusion (2005) Safe as used as a nail primer by trained professionals; insufficient data for retail use by consumers 73 Methyl methacrylate Toxicokinetics Can be absorbed through the skin of humans 74 Animal toxicology Repeated dose-oral: chronic exposure to 400 ppm did not cause tumors in hamsters or rats 75 Genotoxicity Genotoxic in a chromosomal aberration, SCE, and mouse lymphoma assay; not mutagenic in a Salmonella/microsome or liquid incubation assay 1 Carcinogenicity Oral: not carcinogenic in a drinking study using rats Inhalation: up to 400 ppm was not carcinogenic in mice or rats IARC evaluation: inadequate evidence in humans for carcinogenicity; evidence suggesting lack of carcinogenicity in experimental animals; not classifiable as to its carcinogenicity in humans (group 3)
74,75
Irritation and sensitization Dermal-nonhuman: sensitizing at 25% in guinea pigs; minimum induction concentration was 1 M; was a weak contact allergen in a local lymph node assay Human: the frequency of positive reactions among all patients to methyl methacrylate was 7/22; the frequency of positive reactions among patients with artificial nails was 1/10 76 Ethyl methacrylate Genotoxicity Not mutagenic in a Salmonella/microsome assay; genotoxicity in a mouse lymphoma cell assay was considered likely due to a clastogenic mechanism 1 Irritation and sensitization Dermal-human: the frequency of positive reactions among all patients tested was 14/22; the frequency of positive reactions among patients with artificial nails was 7/11 (64%), 76 Discussion items (This ingredient was reviewed for its use nail enhancement products.) The Panel was concerned with the strong sensitization and cross-or coreactivity potential of methacrylates; however, data were submitted that indicated there would be little monomer available for exposure to the skin; genotoxicity data indicated the some methacrylates could produce chromosome damage; the Panel restricted methacrylates to the nail, and they must not come in contact with skin; initial concern that exotherms created from the rapid polymerization of the monomers could damage the nail were alleviated 75 CIR conclusion (2005) Safe as used in nail enhancement products when skin contact is avoided; products containing this ingredient should be accompanied with directions to avoid skin contact, because of the sensitizing potential of methacrylates 75 Butyl methacrylate Animal toxicology Single dose-dermal: 10 cc/kg did not cause mortality in rabbits, but acute dermal irritation was reported; 1 LD 50 value of >2000 mg/kg in rabbits was reported; the LD 50 in guinea pigs was >20 ml/kg Oral: reported oral LD 50 values in rats ranged from >2000 to >20 000 mg/kg Inhalation: reported LC 50 value was 28 469 mg/m 3 rats 75 Repeated dose-oral: in rats, the NOELS were 20 mg/kg/d in a 28-day study, 30 (males) and 300 (females) mg/kg/d in a 45-day study, and <30 (males) and 30 (females) mg/kg/d in a 50-day study Inhalation: caused upper airway irritation in a 28-day study in rats-the NOEL was 1801 mg/m 3 75 Reproductive and developmental toxicity
Oral: a decrease in corpora lutea and implantations was reported in rats; the parental NOAELs were 1000 and 300 mg/kg/d for males and females, respectively Inhalation: threshold concentration for embryotoxic and teratogenic effects in rats was 0.1 mg/m 3 ; slight fetotoxicity was reported in rats exposed to 1200 ppm on days 6 to 20 of gestation 75 (continued) Fiume et al 77S Genotoxicity Not mutagenic in multiple Ames tests with or without metabolic activation; was mutagenic to Salmonella typhimurium TA1538 with metabolic activation in 1 study 75 
Irritation and sensitization
Dermal-nonhuman: a very strong sensitizer in 1 study using guinea pigs; considered a moderate sensitizer in another study using guinea pigs; in a few studies, a sensitization reaction was not produced Human: 1% caused 1 positive reaction in 12 patients in a Draize contact sensitization study; in provocative testing, 1% elicited positive reactions to patch tests Ocular: mildly irritating to rabbit eyes 75 Discussion items (This ingredient was reviewed for its use nail enhancement products.) The Panel was concerned with the strong sensitization and cross-or coreactivity potential of methacrylates; however, data were submitted that indicated there would be little monomer available for exposure to the skin; genotoxicity data indicated the some methacrylates could produce chromosome damage; the Panel restricted methacrylates to the nail, and they must not come in contact with skin; initial concern that exotherms created from the rapid polymerization of the monomers could damage the nail were alleviated. 75 CIR conclusion (2005) Safe as used in nail enhancement products when skin contact is avoided; products containing this ingredient should be accompanied with directions to avoid skin contact, because of the sensitizing potential of methacrylates 75 Isobutyl methacrylate Animal toxicology Single dose-dermal: the reported dermal LD 50 was >20 ml/kg in guinea pigs Oral: reported LD 50 values in rats ranged from >5,000 to 12,800 mg/kg Inhalation: 50% of mice died after exposure to 29.74 mg/L for 289 minutes; was considered a toxic (but not highly toxic) substance by inhalation exposure 75 Genotoxicity Not mutagenic in multiple Ames tests with or without metabolic activation 75 
Dermal-human: 1% caused no positive reaction in 11 patients in a contact sensitization study; in provocative testing, 1% elicited positive reactions to patch tests Ocular: mildly irritating to rabbit eyes 75 Discussion Items (This ingredient was reviewed for its use nail enhancement products.) The Panel was concerned with the strong sensitization and cross-or coreactivity potential of methacrylates; however, data were submitted that indicated there would be little monomer available for exposure to the skin; genotoxicity data indicated the some methacrylates could produce chromosome damage; the Panel restricted methacrylates to the nail, and they must not come in contact with skin; initial concern that exotherms created from the rapid polymerization of the monomers could damage the nail were alleviated. 75 CIR conclusion (2005) Safe as used in nail enhancement products when skin contact is avoided; products containing this ingredient should be accompanied with directions to avoid skin contact, because of the sensitizing potential of methacrylates 75 Lauryl methacrylate Animal toxicology Single dose-oral: no rats dosed with 21.5 ml/kg C12 to C18 methacrylate monomers died Inhalation: the RD 50 was 3,900 mg/m 3 in mice 75 Repeated dose-inhalation: not toxic to rats in a 20-day study 75 
Dermal-nonhuman: strong sensitizer in guinea pigs 75 Discussion items (This ingredient was reviewed for its use nail enhancement products.) The Panel was concerned with the strong sensitization and cross-or coreactivity potential of methacrylates; however, data were submitted that indicated there would be little monomer available for exposure to the skin; genotoxicity data indicated the some methacrylates could produce chromosome damage; the Panel restricted methacrylates to the nail, and they must not come in contact with skin; initial concern that exotherms created from the rapid polymerization of the monomers could damage the nail were alleviated. 75 CIR conclusion (2005) Safe as used in nail enhancement products when skin contact is avoided; products containing this ingredient should be accompanied with directions to avoid skin contact, because of the sensitizing potential of methacrylates 75 (continued)
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International Journal of Toxicology 36( Supplement 2) the unrinsed eyes, the authors stated that this product was considered a borderline irritant.
Acrylates cross polymer. The ocular irritation potential of acrylates cross polymer was evaluated by instilling 0.1 ml of the test material, at a concentration of 50% in olive oil, into the conjunctival sac of 1 eye of 3 Japanese white rabbits. 24 The Draize score was 1.3. (Additional details were not provided.)
Sodium acrylates cross polymer 2. According to an industry MSDS, sodium acrylates cross polymer 2 (as Aqua Keep 10SH-NFC) is not an ocular irritant in rabbits. 41 
Clinical Assessment of Safety
Risk Assessment
Conservative risk assessments were submitted by the Personal Care Products Council's CIR Science and Support Committee (SSC) and by the CIR to address the carcinogenic endpoint for benzene, because it may be used as a solvent in the manufacture of acrylates/C10-30 alkyl acrylates cross polymer. Both assessments assumed the highest reported concentration of residual benzene in acrylates/C10-30 alkyl acrylates cross polymer used as a raw ingredient, the highest reported use concentration in a leave-on product of the raw ingredient polymerized in benzene, 10% evaporation of the residual benzene during manufacturing of the product, 10% benzene absorbed from the product through the skin, and the reported 50th and 95th percentiles of the amount of product used daily.
CIR SSC Risk Assessment 31
The assumptions used to calculate CIR SSC's example exposure assessment were: 50th percentile use ¼7.63 g body lotion used/use day 95th percentile use ¼16.83 g body lotion used/use day 0.4% acrylates/C10-30 alkyl acrylate cross polymer in body lotion 0.41% benzene in acrylates/C10-30 alkyl acrylate cross polymer 10% benzene absorbed percutaneously Estimated Exposure 0.41% benzene in raw material Â 0.4% acrylates/C10-30 alkyl acrylates cross polymer in a body product ¼ 0.00164% benzene in the product 50th 7.63 g body product used/day Â 0.00164% ¼ 0. The SSC Comparison to Risk Level The Environmental Protection Agency (EPA) drinking water concentration associated with 10 6 cancer risk is 1 and 10 mg/L. 47 Assuming consumption of 2 L of water each day, this results in a value of 2 to 20 mg/d. The estimated exposure from the use of a leave-on body product at the 50th percentile, assuming the greatest concentration of acrylates/C10-30 alkyl acrylates cross polymer polymerized in benzene, is in within 75 Genotoxicity Not mutagenic in multiple Ames tests with or without metabolic activation; weakly positive in a mouse lymphoma cell assay with metabolic activation 75 Carcinogenicity Dermal: no increase in skin or visceral tumors in an 80-week study with 25 mg given twice weekly 75 
Irritation and sensitization
Dermal-nonhuman: moderate sensitizer in guinea pigs; not a sensitizer in 1 study Ocular: minimally irritating to rabbit eyes 75 Discussion items (This ingredient was reviewed for its use nail enhancement products.) The Panel was concerned with the strong sensitization and cross-or coreactivity potential of methacrylates; however, data were submitted that indicated there would be little monomer available for exposure to the skin; genotoxicity data indicated the some methacrylates could produce chromosome damage; the Panel restricted methacrylates to the nail, and they must not come in contact with skin; initial concern that exotherms created from the rapid polymerization of the monomers could damage the nail were alleviated. 75 CIR conclusion (2005) Safe as used in nail enhancement products when skin contact is avoided; products containing this ingredient should be accompanied with directions to avoid skin contact, because of the sensitizing potential of methacrylates 23 As Carbopol ETD (tradename) Undiluted (>97.5%) 51 100 patients Material was applied to a 2 cm Â 2 cm pad; patch was applied for 4 consecutive days during weeks 1 to 3;
challenge was performed after 1 week and included 4 applications
Not an irritant or sensitizer 43 As Carbopol Ultrez 21 (tradename) 150 mg of a 10% dilution 111 patients Test material was applied to a 2 cm Â 2 cm pad; patch was applied for 4 consecutive days during weeks 1 to 3; challenge was performed after 1 week and included 4 applications
Not an irritant or sensitizer 44 As Carbopol Ultrez 20 (tradename) 150 mg of a 10% dilution 111 patients Test material was applied to a 2 cm Â 2 cm pad; patch was applied for 4 consecutive days during weeks 1 to 3;
Not an irritant or sensitizer 45 (continued) 
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the range associated with a 10 6 cancer risk, while use at the 95th percentile is just above the range associated with a 10 6 risk. The SSC noted that significant volatilization of benzene would occur during the manufacture of the finished product because the temperatures reached during processing are at or near the boiling point of benzene (80.1 C). They indicated that assuming that only 10% of the residual benzene is volatilized during product manufacture, would yield an exposure within the range associated with a 10 À6 risk for use of a body lotion at the 95th percentile.
CIR's Risk Assessment
The EPA presents the oral slope factor for benzene as a range, based on the assumption that benzene is 100% absorbed after oral exposure. Specifically, the slope factor ranges from 1.5 Â 10 À5 to 5.5 Â 10 À5 (mg/kg/d) À1 . The EPA drinking water concentration range (1-10 mg/L) representing a 10 À6 lifetime cancer risk was calculated from the slope factor range, rounding down the lowest concentration of the range to 1 mg/L and rounding up the highest concentration to 10 mg/L. This estimate (2.2 Â 10 À5 ) is 22 times higher than the upper bound risk estimate considered to be de minimis (10 À6 ).
General Equation
Assuming that 10% of the benzene evaporates during the product manufacturing process reduces the upper bound estimate to 2 Â 10 À5 (2.17 Â 10 À5 Â 90% ¼1.95 Â 10 À5 ), which is still about 20 times higher than 10 À6 .
Using the EPA's lowest cancer slope factor in their range (1.5 Â 10 -5 [mg/kg/d] À1 ), assuming 50th percentile product use, 10% percutaneous absorption, and 10% evaporation during the manufacturing process yields upper bound cancer risk estimates that still exceed 10 À6 by 2-to 3-fold:
Upper Bound Risk for 50th Percentile Exposure 0:41% Â 0:4% Â 7:63 g =d Â 10% Â 1=70½ kg À1 Â 10 6 mg=g Â 1:5 Â 10 À5 ½ mg=kg=d À1 Â 90%
The SSC reported that the cancer risk would <10 À6 , by comparing the estimated daily absorbed dose of benzene from the product to drinking water concentrations that EPA suggests represents a 10 À6 lifetime risk. However, CIR calculated upper bound lifetime cancer risk estimates up to 20-fold greater than 10 À6 , based on EPA's cancer slope factors for benzene.
Industrial Exposure Limits
According to an industry MSDS, no exposure limits have been established for acrylates/C10-30 alkyl acrylate cross polymer. 39 The industry-recommended permissible exposure limits for respirable polyacrylate dusts is 0.05 mg/m 3 . Breathing of dust may cause coughing, mucous production, and shortness of breath. According to an industry MSDS, the exposure limit for respirable sodium acrylates cross polymer 2 dust (particle size <10 mm) is 0.05 mg/m 3 . 41
Summary
The cross-linked alkyl acrylates are cross-linked polymers and are very large molecules that consist of comonomers of acrylic acid, sodium acrylate, methacrylic acid, and/or alkyl acrylate, and they share chemical properties, including a general lack of chemical reactivity. Cross-linked alkyl acrylates are typically produced via free radical, head-to tail chainpropagation polymerization. Ethyl acetate þ cyclohexane, water, n-hexane, and benzene are all named as solvents. Because of the manner in which these polymers are created and the mixture of monomers and cross-linking agents that can be used, 2 polymers that have the same INCI name can have very different physical consistencies. Small amounts of residual monomer and/or solvent may be present in the raw ingredients.
Cross-linked alkyl acrylates are reported to function in cosmetic formulations as absorbents, film formers, emulsion stabilizers, viscosity increasing agents, suspending agents, binders, and/or skin-conditioning agents. In 2011, it was reported that acrylates/C10-30 alkyl acrylate cross polymer was used in 1,696 cosmetic formulations; 1,365 of those uses are in leave-on products, and the reported concentration of use in these leave-on products is up to 5%. According to industry data, acrylates/ethylhexyl acrylate cross polymer had the highest concentration of use in a leaveon product at 6%; the highest concentration of use reported in rinse-off products was 5% acrylates/C10-30 alkyl acrylate cross polymer.
Toxicokinetic data were not found in the published literature. Little toxicity data were available; the acute dermal and oral toxicity data that were found indicated that these ingredients are not very toxic. The little genotoxicity data that were available reported negative results in Ames tests. Carcinogenicity data were not found in the published literature for the polymers, but data were available for the monomers.
In an alternative method study, acrylates/vinyl neodecanoate cross polymer was predicted to be a nonirritant. The nonhuman studies reported no to slight irritation with undiluted and weak sensitization with 2% aq, acrylates/C10-30 alkyl acrylate cross polymer, no irritation with acrylates cross polymer at 30% in olive oil, and no irritation or sensitization with sodium acrylates cross polymer 2 (concentration not specified). Mostly, human testing with undiluted acrylates/C10-30 alkyl acrylate cross polymer, acrylates cross polymer, and acrylates/ ethylhexyl acrylate cross polymer, up to 2.5% aq acrylates/ vinyl isodecanoate cross polymer, 1% aq dilutions of formulations containing 2% acrylates/vinyl neodecanoate cross polymer, and formulations containing up to 2.6% lauryl methacrylate/glycol dimethacrylate cross polymers do not indicate any dermal irritation or sensitization. The only exception was a weak irritant response noted during an intensified Shelanski HRIPT with undiluted acrylates/C10-30 alkyl acrylate cross polymer.
Alternative test methods for ocular irritation indicated that acrylates/vinyl isodecanoate cross polymer and a formulation containing 1% lauryl methacrylate/glycol dimethacrylate cross polymer are not likely ocular irritants. In studies using rabbits, undiluted acrylates/C10-30 alkyl acrylate cross polymer produced minimal to moderate irritation, and it was considered a borderline irritant in unrinsed rabbit eyes. Acrylates cross polymer, at 50% in olive oil, and sodium acrylates cross polymer 2 did not appear to be ocular irritants in rabbit eyes.
Two different risk assessments evaluating the carcinogenic endpoint for benzene that may be present in acrylates/ C10-30 alkyl acrylates cross polymer resulted in different lifetime risk. One found that the risk was within the range associated with a 10 6 cancer risk, while the other reported a 20-fold greater risk.
Discussion
Few published data were available on the cross-linked alkyl acrylates. The CIR Expert Panel was provided with some summary information on the monomers for their use in evaluating these cross polymers.
The Panel noted that these cross-linked alkyl acrylates are macromolecules that are not expected to pass through the stratum corneum of the skin, so significant dermal absorption is not expected. Therefore, topically applied cosmetics are not expected to result in systemic or reproductive and developmental toxicity or to have genotoxic or carcinogenic effects upon use.
The Panel noted that cosmetic products containing these ingredients are reportedly used around the eyes, on the lips, and on other mucous membranes. Thus, cross-linked alkyl acrylates could be absorbed systemically through the relatively moist, thin stratum cornea of the conjunctiva, lips, and other mucous membranes, and through ingestion when applied to the lips. However, the Panel noted that any absorption through healthy intact mucous membranes is likely to be not significant, primarily because of the relatively large molecular sizes. Furthermore, the chemically inert nature of the polymers precludes degradation to smaller absorbable species. Absorption of the polymers and their residual monomers in cosmetic products also would be limited after application to the lips or eye area based on the relatively small fractions of the applied products that might be inadvertently ingested or make direct contact with the conjunctiva.
The Panel addressed the concern of residual monomer or solvent that might be present in the cross polymers. In most cases, taking into consideration the low amount of residual monomer in the cross polymers and the low use concentration of the polymers themselves, the Panel was not concerned that the presence of residual monomer would result in adverse effects. However, the use of benzene as a solvent is an exception and did cause concern. It cannot be predicted with certainty what quantity of benzene would be volatilized/leached from acrylates/C10-30 alkyl acrylates cross polymer during manufacture, formulation, or use. While some benzene is inevitably volatilized during manufacture, some benzene may be trapped in the polymer matrix and may leach out during formulation and use, but there is no way of knowing how much (or if any) benzene would leach out without appropriate data from a representative product formulation.
Conservative risk assessments were submitted by industry and by the CIR to address the carcinogenic endpoint for benzene, because it may be used as a solvent in the manufacture of acrylates/C10-30 alkyl acrylates cross polymer. Both assessments assumed the highest reported concentration of residual benzene in acrylates/C10-30 alkyl acrylates cross polymer used as a raw ingredient, the highest reported use concentration in a leave-on product of the raw ingredient polymerized in benzene, 10% evaporation of the residual benzene during manufacturing of the product, 10% benzene absorbed from the product through the skin, and the reported 95th percentile of the amount of product used daily. Industry reported that the cancer risk would <10 À6 , by comparing the estimated daily absorbed dose of benzene from the product to drinking water concentrations that EPA suggests represents a 10 À6 lifetime risk. However, CIR calculated upper bound lifetime cancer risk estimates up to 20-fold greater than 10 À6 , based on EPA's cancer slope factors for benzene. Given the uncertainty of the assumptions used in the risk assessment, the Panel was not comfortable with using a risk assessment in evaluating the carcinogenic endpoint. Therefore, the Panel found the data insufficient to conclude that the residual benzene levels are safe.
Because these ingredients can be used in products that may be aerosolized, including sprays and powders, the Panel discussed the issue of potential inhalation toxicity. The limited data available from an acute exposure study suggested little potential for pulmonary overload or other respiratory effects at relevant doses. The Panel considered other data available to characterize the potential for cross-linked alkyl acrylates to cause systemic toxicity, irritation, sensitization, or other effects. They noted the lack of systemic toxicity at high doses in several acute oral exposure studies, little or no irritation or sensitization in multiple tests of dermal and ocular exposure, and the absence of genotoxicity in Ames tests. In addition, these ingredients are macromolecules, insoluble in water, and chemically inert under physiological conditions or conditions of use, which supports the view that they are unlikely to be absorbed or cause local effects in the respiratory tract. Further, these ingredients are reportedly used at concentrations 4% in cosmetic products that may be aerosolized. The Panel noted that 95% to 99% of particles produced in cosmetic aerosols would not be respirable to any appreciable extent. Coupled with the small actual exposure in the breathing zone and the concentrations at which the ingredients are used, this information indicates that inhalation would not be a significant route of exposure that might lead to local respiratory or systemic toxic effects.
Conclusion
The CIR Expert Panel concluded that the cross-linked alkyl acrylates listed below are safe in the present practices of use and concentration described in this safety assessment, except when they are polymerized in benzene. Acrylates/C10-30 alkyl acrylate cross polymer may be polymerized in benzene, and the available data are insufficient to make a determination of safety for this cross-linked alkyl acrylate when it is polymerized in benzene.
